Latest filing published 08 Sept 2022 for Avanos Medical, INC., €49k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
David Edward Ball: trading record in brief
David Edward Ball, listed as senior executive, appears in our data through filings on Avanos Medical, Inc. shares, published by SEC (Form 4). In total, 7 filings cover trades dated from 7 May 2020 to 6 September 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 8 September 2022, the filings show a share grant worth €18k in Avanos Medical, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David Edward Ball
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,015 shares@ US$23.8738.5% of flowCommon StockSEC:0001775747-22-000003:0
- 11,241 shares0Common StockSEC:0001606498-22-000042:0
- 1,411 shares@ US$31.2244.4% of flowCommon StockSEC:0001628280-21-025462:0
3 of 3 declarations
